Truist lowered its DraftKings price target to $43 while maintaining a buy rating following the prediction markets launch.
Background The growing population of patients with adult congenital heart disease (ACHD) present complex lifelong care needs ...
Predictions markets continue to capture headlines as the year comes to a close, with DraftKings and the CFTC at the centre of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback